Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
orphan-drug
Press Release
Jun 27, 2023
ForCast Orthopedics Receives Orphan Drug Designation From FDA for the Treatment of Periprosthetic Joint Infection (PJI)
Read More
Press Release
Apr 11, 2023
Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Multiple Myeloma
Read More
Press Release
Jan 5, 2022
Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Acute Myeloid Leukemia
Read More
Press Release
Sep 28, 2018
Venerated and Vital: Using Lipid Based Delivery for Fast and Efficient Early Phase Development, Upcoming Webinar Hosted by Xtalks
Read More
Press Release
Oct 31, 2017
MitosolĀ®'s Orphan Drug Designation is Expanded for All Glaucoma Surgery
St. Louis ophthalmic company expands designation to include all glaucoma surgery
Read More
Press Release
Jul 26, 2017
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients With Sickle Cell Disease Using Altemia Capsules
Read More
Press Release
Jun 15, 2011
Lamellar Biomedical Secures Its First Orphan Drug Licence
Provides 10-year Market Exclusivity for the treatment of Cystic Fibrosis
Read More
First
Prev
1
Next
Last